Switch to:
More From Other Websites
Newly Profitable Medivation Riding High On Drug Sales Nov 28 2014
Quick Look at the Lg Cap All Time Highs... Nov 25 2014
Cramer: Not too late to buy Regeneron Nov 24 2014
Celgene's PDE4 Inhibitor Otezla Gets Positive CHMP Opinion Nov 24 2014
Nasdaq Climbs, But AT&T, Verizon, Drag Dow Down Nov 24 2014
Chip Stocks, Biotechs Lead Another Nasdaq Rally Nov 24 2014
5 Trade Ideas for Celgene this Week Nov 24 2014
Alibaba Among 5 Top Stocks With Top Profit Margins Nov 23 2014
Cramer: Stick with what's working Nov 21 2014
AbbVie, Celgene, Sanofi Drugs Get EU Endorsements Nov 21 2014
Trade-Ideas: Celgene (CELG) Is Today's Momo Momentum Stock Nov 21 2014
Celgene Receives Positive CHMP Opinion for OTEZLA® (apremilast), the First Oral PDE4 Inhibitor for... Nov 21 2014
Europe gives green light to AbbVie hepatitis C medicine, others Nov 21 2014
Celgene Receives Positive CHMP Opinion for OTEZLA® (apremilast), the First Oral PDE4 Inhibitor for... Nov 21 2014
Chef Michael Ferraro, the Pancreatic Cancer Action Network and Meals to Heal Team up with Celgene to... Nov 20 2014
Celgene Up on Encouraging Long-Term Phase III Otezla Data Nov 19 2014
Cramer shares hazards of skepticism Nov 18 2014
Oral OTEZLA® (Apremilast) Showed Sustained Clinical Response over Two Years in Patients with Active... Nov 18 2014
UPDATE: Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Well Tolerated and... Nov 18 2014
Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Safe and Increases CD4... Nov 17 2014
Biotech correction coming? 16 trades, 55 seconds Nov 14 2014
Stock Market Treads Water; Earnings Drive BitAuto Nov 14 2014
Stocks Drift Lower As Biotechs Tumble Nov 14 2014
Stocks Mixed; Amazon Jumps On Book Deal Nov 14 2014
Global Survey Finds That Pancreatic Cancer, a Leading Cause of Cancer Deaths, is Virtually Unknown... Nov 13 2014
Celgene Corporation to Webcast at Upcoming Investor Conferences and Medical Congress Oct 31 2014
Acceleron Collaboration Partner Celgene to Present Data at the American Society of Nephrology Kidney... Oct 23 2014
Celgene beats Street 3Q forecasts Oct 23 2014
Phase II Data in Crohn's Disease for Celgene's Oral Antisense Therapy GED-0301 to Be Presented at... Oct 20 2014
Celgene Reports First Quarter 2014 Operating and Financial Results Apr 24 2014
Drug firm exec gets 16 months in inside-trade case Apr 22 2014
Acceleron, Celgene and Collaborators Announce Two Publications in Nature Medicine Describing... Mar 24 2014
FDA approves specialty arthritis drug from Celgene Mar 21 2014
Celgene Reiterates Commitment to Improving Pancreatic Cancer Care in Europe, Through Significant... Mar 19 2014
Acceleron and Celgene Announce Interim Clinical Data for Sotatercept in Patients with End Stage... Mar 17 2014
Celgene Corporation Board of Directors Recommends to Our Stockholders a Two-for-One Stock Split Feb 13 2014
Celgene Corporation to Present at Investor Conferences in February and March Feb 11 2014
World Cancer Day: A Single Day Is Never Enough Feb 04 2014
Celgene Reports Fourth Quarter and Full Year 2013 Operating and Financial Results Jan 30 2014
Celgene Corporation to Announce Fourth Quarter and Full Year 2013 Results on January 30, 2014 Jan 22 2014
Regeneron slips after getting a boost from outlook Jan 15 2014
Celgene Corporation Announces 2014 Financial Outlook and Preliminary 2013 Results Jan 13 2014
Celgene cuts 4Q, 2013 adj. profit outlooks Jan 13 2014
Celgene Corporation to Present 2013 Unaudited Financial Results and Updated Financial Outlook at the... Jan 10 2014
EU clears Celgene's Abraxane for pancreatic cancer Jan 07 2014
ABRAXANE® Plus gemcitabine Receives European Marketing Authorization for First-Line Treatment of... Jan 07 2014
Celgene Corporation to Present at the 32nd Annual J.P. Morgan Healthcare Conference Jan 02 2014
REVLIMID® (lenalidomide)-Treated Patients with Deletion-5q MDS Who Achieve Transfusion-Independence... Dec 09 2013
First Analysis of Extended Dosing with Celgene Epigenetic Agent CC-486 in Patients with Higher-Risk... Dec 07 2013
OncoMed stock doubles after cancer drug deal with Celgene Dec 03 2013


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK